-
51
المؤلفون: Amat-Santos IJ, Sánchez-Luna JP, Abu-Assi E, Melendo Viu M, Cruz-Gonzalez I, Nombela-Franco L, Muñoz García AJ, García Blas S, de la Torre Hernandez JM, Romaguera R, Sánchez-Recalde Á, Díez Gil JL, López Otero D, Gheorge L, Ibáñez B, Iñiguez Romo A, Raposeiras-Roubín S
المصدر: EUROPEAN JOURNAL OF HEART FAILURE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instnameمصطلحات موضوعية: cardiovascular system, Dapagliflozin, Heart Failure, Sodium-glucose co-transporter 2 inhibitor, Trial Design
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2a47e53508a5881b115ce3ad255f92a9Test
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15020Test -
52
المؤلفون: Dhruv Mahtta, Aliza Hussain, Salim S. Virani, Mahmoud Al Rifai, Vardhmaan Jain, Jing Liu
المصدر: Current Atherosclerosis Reports
مصطلحات موضوعية: medicine.medical_specialty, Acute coronary syndrome, Exacerbation, Evinacumab, Type 2 diabetes, Disease, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Omega-3 fatty acids, Humans, Coronary computed tomography angiography, Medicine, 030212 general & internal medicine, Renal Insufficiency, Chronic, Polypill, Intensive care medicine, Heart Failure, business.industry, Statins, American Heart Association, medicine.disease, United States, Cardiovascular prevention, Sodium-glucose co-transporter inhibitors, Diabetes Mellitus, Type 2, Heart failure, Reviews and New Research Implications (S. Virani, Section Editor), Cardiology and Cardiovascular Medicine, business, Kidney disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940bc03331ca8ce358ac9cd59198d2a9Test
https://doi.org/10.1007/s11883-020-00900-5Test -
53
المؤلفون: Makoto Abe, Katsuomi Hoshino, Takahiko Kai, Jun Nakamura, Kazunori Watanabe, Satoshi Oka, Akinori Watanabe
المصدر: BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-11 (2021)مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, Exacerbation, Diabetic Cardiomyopathies, Cardiomyopathy, Heart failure, 030204 cardiovascular system & hematology, Ventricular Function, Left, Coronary artery disease, 03 medical and health sciences, Ventricular Dysfunction, Left, 0302 clinical medicine, Glucosides, Diabetes mellitus, Internal medicine, medicine, Empagliflozin, Left ventricular global longitudinal strain, Diseases of the circulatory (Cardiovascular) system, Humans, 030212 general & internal medicine, Prospective Studies, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Angiology, Aged, Left ventricular dysfunction, business.industry, Sodium–glucose co-transporter 2 inhibitor, Recovery of Function, Middle Aged, medicine.disease, Diabetes mellitus-related cardiomyopathy, Cardiac surgery, Treatment Outcome, Diabetes Mellitus, Type 2, RC666-701, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e90625afe058ea911725a4c7e9cc554Test
https://pubmed.ncbi.nlm.nih.gov/33926386Test -
54
المؤلفون: Keshav Gopal, Jadin J. Chahade, Ryekjang Kim, John R. Ussher
المصدر: Frontiers in Physiology
Frontiers in Physiology, Vol 11 (2020)مصطلحات موضوعية: medicine.medical_specialty, endocrine system diseases, type 2 diabetes mellitus, Physiology, Diastole, sodium-glucose co-transporter 2 inhibitors, Review, dipeptidyl peptidase 4 inhibitors, 030204 cardiovascular system & hematology, lcsh:Physiology, 03 medical and health sciences, 0302 clinical medicine, Physiology (medical), Diabetic cardiomyopathy, Internal medicine, diabetic cardiomyopathy, medicine, 030212 general & internal medicine, Dipeptidyl peptidase-4, glucagon-like peptide-1 receptor agonists, Ejection fraction, lcsh:QP1-981, business.industry, diastolic function, Type 2 Diabetes Mellitus, medicine.disease, 3. Good health, Metformin, Heart failure, Cardiology, metformin, Heart failure with preserved ejection fraction, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b22c2e4f9f2c24fa0fd07253470915caTest
https://doi.org/10.3389/fphys.2020.603247Test -
55
المؤلفون: Pieter Martens, Wilfried Mullens
المصدر: European Journal of Heart Failure
مصطلحات موضوعية: medicine.drug_class, Sodium, Empagliflozin, chemistry.chemical_element, Pharmacology, Kidney, Sodium–glucose co‐transporter 2 inhibitors, chemistry.chemical_compound, Glucosides, Medicine, Humans, Benzhydryl compounds, Benzhydryl Compounds, Research Articles, Heart Failure, business.industry, medicine.disease, Osmotic diuretic, Diuretics, Osmotic, Diuresis, Acute Heart Failure, chemistry, Heart failure, Cardiology and Cardiovascular Medicine, business, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f3200ee938d5fba19f06acfd442099fTest
https://pubmed.ncbi.nlm.nih.gov/33251643Test -
56
المؤلفون: Giuseppe Rosano, Felipe Martinez, David K.L. Quek
المصدر: Cardiac Failure Review, Vol 6, Iss, Pp-(2020)
Cardiac Failure Reviewمصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, medicine.medical_specialty, Cardiomyopathy, heart failure, sodium-glucose co-transporter 2 inhibitors, Type 2 diabetes, 030204 cardiovascular system & hematology, Cardiovascular, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Diabetes mellitus, medicine, Diseases of the circulatory (Cardiovascular) system, 030212 general & internal medicine, Myocardial infarction, Dapagliflozin, clinical trials, Ejection fraction, business.industry, Atrial fibrillation, medicine.disease, Treatment, chemistry, lcsh:RC666-701, RC666-701, Heart failure, Cardiology, type 2 diabetes, Cardiology and Cardiovascular Medicine, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e51c71ce87f6e898e56a01bef4cb04e0Test
https://doi.org/10.15420/cfr.2020.23Test -
57
المؤلفون: Gerasimos Filippatos, Faiez Zannad, Martina Brueckmann, Cordula Zeller, Emperor Trial Committees, João Pedro Ferreira, Investigators, Waheed Jamal, Milton Packer, Stuart J. Pocock, Stefan D. Anker, Javed Butler
المصدر: European Journal of Heart Failure
مصطلحات موضوعية: medicine.medical_specialty, Renal function, 030204 cardiovascular system & hematology, Sodium–glucose co‐transporter 2 inhibitors, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Internal medicine, Empagliflozin, Clinical endpoint, medicine, Humans, Dapagliflozin, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Randomized Controlled Trials as Topic, Heart Failure, Ejection fraction, Study Design, business.industry, Cardiovascular Agents, Stroke Volume, medicine.disease, Heart failure with reduced ejection fraction, Renal outcomes, Transplantation, Hospitalization, Heart failure with preserved ejection fraction, chemistry, Heart failure, Cardiology and Cardiovascular Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbabf8830a5d2deda8f2034e5e5abf40Test
https://pubmed.ncbi.nlm.nih.gov/33251659Test -
58
المصدر: Volume: 3, Issue: Supplement 1 85-86
Turkish Journal of Internal Medicineمصطلحات موضوعية: Starvation, General and Internal Medicine, Pediatrics, medicine.medical_specialty, endocrine system diseases, Diabetic ketoacidosis, Dapagliflozin,sodium-glucose co-transporter 2 inhibitors,euglycemic ketoacidosis, business.industry, nutritional and metabolic diseases, Antidiabetic treatment, medicine.disease, Ketoacidosis, Acute illness, Food and drug administration, chemistry.chemical_compound, chemistry, General Earth and Planetary Sciences, Medicine, Dapagliflozin, medicine.symptom, business, Genel ve Dahili Tıp, General Environmental Science, Carbohydrate intake
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::386ce59962bf0f5ddc910c26644150cdTest
https://doi.org/10.46310/tjim.877156Test -
59
المؤلفون: García-Carro, Clara, Vergara, Ander, Agraz Pamplona, Irene, Jacobs-Cachá, Conxita, Espinel, Eugenia, Seron, Daniel, Soler, María José, Universitat Autònoma de Barcelona
المساهمون: Institut Català de la Salut, [García-Carro C, Vergara A] Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Servei de Nefrologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Agraz I, Jacobs-Cachá C, Espinel E, Seron D, Soler MJ] Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Servei de Nefrologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Red de Investigación Renal (REDINREN), Instituto Carlos III, Madrid, Spain., Vall d'Hebron Barcelona Hospital Campus
المصدر: Journal of Clinical Medicine
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Clinical Medicine, Vol 8, Iss 6, p 864 (2019)
Scientiaمصطلحات موضوعية: Nefropaties diabètiques - Fisiologia patològica, Sodium-glucose co-transporter 2 inhibitors, Otros calificadores::/fisiología [Otros calificadores], Other subheadings::/physiology [Other subheadings], lcsh:Medicine, 030209 endocrinology & metabolism, sodium-glucose co-transporter 2 inhibitors, Type 2 diabetes, Disease, Review, dipeptidyl peptidase 4 inhibitors, 030204 cardiovascular system & hematology, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Bioinformatics, acciones y usos químicos::acciones farmacológicas::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::hipoglicemiantes::inhibidores de la dipeptidil-peptidasa IV [COMPUESTOS QUÍMICOS Y DROGAS], Glucagon-like peptide-1 receptor agonists, Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Nephropathies [DISEASES], Chemical Actions and Uses::Pharmacologic Actions::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hypoglycemic Agents::Dipeptidyl-Peptidase IV Inhibitors [CHEMICALS AND DRUGS], 03 medical and health sciences, 0302 clinical medicine, reno-cardiovascular protection, Diabetes management, Diabetes mellitus, medicine, Nefropaties diabètiques - Tractament, Other subheadings::/therapeutic use [Other subheadings], Diabetic kidney disease, Reno-cardiovascular protection, Dipeptidyl peptidase-4, Otros calificadores::Otros calificadores::/tratamiento farmacológico [Otros calificadores], glucagon-like peptide-1 receptor agonists, diabetes, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, lcsh:R, Diabetes, General Medicine, medicine.disease, Antidiabètics - Ús terapèutic, diabetic kidney disease, enfermedades del sistema endocrino::diabetes mellitus::complicaciones de la diabetes::nefropatías diabéticas [ENFERMEDADES], Dipeptidyl peptidase 4 inhibitors, Heart failure, Albuminuria, medicine.symptom, business, Kidney disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858333aa069a6cc2c000519864e3a259Test
https://pubmed.ncbi.nlm.nih.gov/31212945Test -
60
المؤلفون: Piotr Ponikowski, Investigators, Silvio E. Inzucchi, Dapa-Hf Trial Committees, Lars Køber, Felipe Martinez, Mikaela Sjöstrand, David L. DeMets, Anna Maria Langkilde, Scott D. Solomon, Mikhail Kosiborod, Olof Bengtsson, Marc S. Sabatine, John J.V. McMurray
المصدر: European Journal of Heart Failure
DAPA-HF Committees and Investigators 2019, ' A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) ', European Journal of Heart Failure, vol. 21, no. 5, pp. 665-675 . https://doi.org/10.1002/ejhf.1432Testمصطلحات موضوعية: medicine.medical_specialty, Trial Designs, Type 2 diabetes, Disease, 030204 cardiovascular system & hematology, sodium–glucose co-transporter 2 inhibitor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Glucosides, Internal medicine, Diabetes mellitus, Natriuretic Peptide, Brain, Type 2 diabetes mellitus, medicine, Humans, Patient Reported Outcome Measures, Dapagliflozin, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, Heart Failure, Ejection fraction, Study Design, business.industry, Type 2 Diabetes Mellitus, Stroke Volume, medicine.disease, Peptide Fragments, Clinical trial, Hospitalization, Sodium–glucose co‐transporter 2 inhibitor, chemistry, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Heart failure, Chronic Disease, Cardiology, Cardiology and Cardiovascular Medicine, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063f8efdbe365cc37e52508e815781b8Test
https://pubmed.ncbi.nlm.nih.gov/30895697Test
